Intra-Cellular Therapies Inc
Change company Symbol lookup
Select an option...
ITCI Intra-Cellular Therapies Inc
IART Integra Lifesciences Holdings Corp
R Ryder System Inc
AAPL Apple Inc
IIM Invesco Value Municipal Income Trust
QQQ Invesco QQQ Trust
VZ Verizon Communications Inc
CHTR Charter Communications Inc
SPB Spectrum Brands Holdings Inc
USB US Bancorp
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company provides CAPLYTA (lumateperone) for the treatment of schizophrenia in adults. The CAPLYTA is a prescription medicine used to treat the depressive episodes in adults with bipolar I or II, that can be taken alone or with lithium or valproate. The Company's pipeline is focused on three platforms: lumateperone and follow-on compounds, a phosphodiesterase 1 (PDE1) inhibitor platform and discovery platform which includes ITI-333 a novel compound with high affinity at serotonin 5-HT2A, dopamine D1 and mu opioid (MOP) receptors. The Company’s subsidiaries are ITI, Inc. (ITI) and ITI Limited.

Price
Delayed
$52.39
Day's Change
-1.19 (-2.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
54.20
Day's Low
51.24
Volume
(Below Average)

Today's volume of 694,742 shares is on pace to be lower than ITCI's 10-day average volume of 1,016,423 shares.

694,742

Upcoming Events

ITCI's fiscal year ends in December
There are no upcoming events for ITCI

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 9, 2022Q2 2022 Earnings Release-$0.92-$0.88 to -$0.67-$0.85
May 10, 2022Q1 2022 Earnings Release-$0.78-$1.07 to -$0.79-$0.65
March 1, 2022Q4 2021 Earnings Release-$1.05-$1.08 to -$0.85-$0.76
November 9, 2021Q3 2021 Earnings Release-$0.95-$0.97 to -$0.82-$0.79

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.